iScribe

San Mateo, United States Founded: 1999 • Age: 27 yrs
Mobile, handheld, wireless electronic prescribing technology was developed for healthcare.

About iScribe

iScribe is a Healthcare company based in San Mateo (United States) founded in 1999. Mobile, handheld, wireless electronic prescribing technology was developed for healthcare. iScribe has raised $17.1 million across 2 funding rounds from investors including Kleiner Perkins, Earlybird and Galen Partners. Its chief executive, as recorded, is David Levinson. Its focus areas include HealthTech, Healthcare IT, Provider and Hospital Information Systems. Its competitors include DoseSpot, AssistRx and Prematics; 1 of its 3 listed competitors has raised funding.

Company details

iScribe was founded in 1999 in San Mateo, United States, as a healthcare technology company. Mobile, handheld, wireless electronic prescribing solutions were developed, including the Windows CE-based iScribe i3000 system, which utilized a Cassiopeia handheld device, prescription software, practice management interface, and wireless printer. Additionally, the Palm OS-based iScribe i5000 was created as a pocket-sized device for radio frequency or cellular communication to secure networks.

  • Headquarters San Mateo, United States
  • Sectors
    Healthcare
  • Website iscribe.com
Key Metrics
  • Total Equity Funding
    $17.1M (USD)

    in 2 rounds

  • Latest Funding Round
    $15M (USD), Series D

    Apr 2001

  • Investors

Funding Insights of iScribe

iScribe has successfully raised a total of $17.1M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $15 million completed in April 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $17.1M
  • Total Rounds 2
  • Last Round Series D β€” $15M
  • First Round $2.1M

    (Mar 2000)

  • Investors Count 5

All 2 funding rounds of iScribe with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2001$15MSeries D––
Mar 2000$2.1MSeries B––
Valuation history

5 investors in total: 5 institutional.

Investors in iScribe

iScribe has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Kleiner Perkins, Earlybird and Galen Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
earlybird.comBerlin, Germany
PE firm investing in the US
galen.comStamford, United States
Life science & tech focused VC firm investing in the US
domainvc.comPrinceton, United States
Venture capital firm investing in early-stage tech startups
1972kleinerperkins.comMenlo Park, United States
US life sciences companies are invested in by Skyline Ventures.
skylineventures.comPalo Alto, United States
Premium access

Investor details for iScribe

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of iScribe

1 people are tracked at iScribe (1 in leadership).

NameRoleGroup
David Levinson
CEO & PresidentLeadership
Premium access

Complete people profiles for iScribe

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of iScribe

3 dated milestones of iScribe across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded iScribe is founded.
  2. Funding First funding round of $2.1M.
  3. Funding Latest funding round, Series D, of $15.0M.

Competitors of iScribe

iScribe has 3 listed competitors in our database, 1 of them funded. They include DoseSpot, AssistRx and Prematics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dosespot.com2009Waltham, United States
E-prescribing integration services are offered for healthcare platforms.
assistrx.com2009Orlando, United States476
Patient-focused software solution for prescribing specialty medications
prematics.com2005Vienna, United States$10.79M
Mobile based medication management and e-prescribe platform for health care providers
Premium access

Detailed competitors of iScribe

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as iScribe (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Iscribe

Premium access

Complete news archive for iScribe

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about iScribe

iScribe was founded in 1999 and raised its 1st funding round 1 year after it was founded.

iScribe is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.

David Levinson is the CEO of iScribe, as recorded in our data.

iScribe is a funded company, having raised a total of $17.1M across 2 funding rounds to date. The company's 1st funding round was a Series B of $2.1M, raised on Mar 2000.

iScribe was founded in 1999 in San Mateo, United States, as a healthcare technology company. Mobile, handheld, wireless electronic prescribing solutions were developed, including the Windows CE-based iScribe i3000 system, which utilized a Cassiopeia handheld device, prescription software, practice management interface, and wireless printer. Additionally, the Palm OS-based iScribe i5000 was created as a pocket-sized device for radio frequency or cellular communication to secure networks.

iScribe's top competitors include AssistRx, DoseSpot and Prematics.

iScribe has 5 investors. Key investors include Kleiner Perkins, Earlybird, Galen Partners, Domain Associates, and Skyline Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available